Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Staloral SLIT in Chinese Asthmatic Patients
NCT00660452Phase 3Completed
- Sponsor
- Stallergenes Greer
- Start
- Oct 2007
- Primary completion
- Jul 2009
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in allergic asthma comparing Staloral with Placebo (2 arms). Primary endpoint: Proportion of patients who achieve well-controlled asthma. Started Oct 2007; status: completed.
02
Drugs
dermatophagoides pteronyssinus extract
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT00660452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00660452.